Aemetis (NASDAQ:AMTX) Shares Cross Below 200-Day Moving Average – Here’s What Happened

Aemetis, Inc. (NASDAQ:AMTX)’s share price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.81 and traded as low as $1.95. Aemetis shares last traded at $2.00, with a volume of 688,056 shares.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on AMTX. HC Wainwright restated a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a research note on Monday, December 23rd. StockNews.com upgraded shares of Aemetis to a “sell” rating in a research note on Wednesday, February 5th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $12.95.

Aemetis Stock Down 3.4 %

The stock’s 50-day moving average is $2.64 and its 200-day moving average is $2.81. The firm has a market cap of $102.30 million, a P/E ratio of -0.88 and a beta of 1.44.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same period last year, the firm posted ($0.59) EPS. As a group, analysts expect that Aemetis, Inc. will post -2.07 EPS for the current fiscal year.

Hedge Funds Weigh In On Aemetis

A number of institutional investors and hedge funds have recently bought and sold shares of AMTX. Geode Capital Management LLC increased its holdings in Aemetis by 1.2% in the 4th quarter. Geode Capital Management LLC now owns 934,993 shares of the specialty chemicals company’s stock valued at $2,516,000 after buying an additional 10,700 shares during the period. State Street Corp increased its holdings in Aemetis by 36.1% in the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after buying an additional 185,304 shares during the period. JPMorgan Chase & Co. increased its holdings in Aemetis by 515.9% in the 4th quarter. JPMorgan Chase & Co. now owns 120,716 shares of the specialty chemicals company’s stock valued at $325,000 after buying an additional 101,116 shares during the period. Bank of New York Mellon Corp increased its holdings in Aemetis by 29.6% in the 4th quarter. Bank of New York Mellon Corp now owns 91,880 shares of the specialty chemicals company’s stock valued at $247,000 after buying an additional 20,961 shares during the period. Finally, Wellington Management Group LLP bought a new stake in Aemetis in the 3rd quarter valued at $177,000. Institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.